NewGenIVF says K25.ai stake doubles to US$20 million after Series A valuation jump
NIVF•K25.ai stake value rises after Series A valuation increase
NewGenIVF says its US$10 million Pre-A investment in K25.ai is now valued at US$20 million following K25.ai’s US$200 million post-money Series A valuation.
The stake was about 10% at entry, implying an unrealized gain of about US$10 million expected to be booked in 2026.
K25.ai’s valuation doubled from US$100 million in under 60 days, supported by Amber Group in the Series A round.




